Global Management Structure

The Astellas Group has established a management structure as described below.

Top Management (as of April 2024)

In order to build an optimal management system capable of agile and appropriate decision making, Astellas maintains a global organizational structure covering the entire Group across nearly all of its divisions including those of Research, Development, Manufacturing, and administrative functions, and appoints Top Management to take charge of such activities. Top Management consists of the Representative Director, President and CEO and members who are in charge of each business area.
 

Naoki Okamura Representative Director, President and Chief Executive Officer (CEO)

Organization in charge

Advocacy, API External Relations, Audit & Supervisory Committee Office, Communications & Investor Relations, Internal Audit, Quality Assurance
Close

Katsuyoshi Sugita Representative Director, Executive Vice President, Chief People Officer and Chief Ethics & Compliance Officer (CPO & CECO)

Organization in charge

CPO & CEOO Office, Ethics & Compliance, Human Resources Close

Yoshitsugu Shitaka, Ph.D. Chief Scientific Officer (CScO)

Organization in charge

CScO Office, Applied Research & Operations, Discovery Accelerator, Engineered Small Molecules, Gene Therapy Research & Technical Operations, Immuno-Oncology, Institute for Regenerative Medicine, Open Innovation Management, Universal Cells, Xyphos Biosciences
Close

Tadaaki Taniguchi, M.D., Ph.D. Chief Medical Officer (CMO)

Organization in charge

CMO Office, Biopharma Development, Cell and Gene Therapy Development, Clinical Operations and China Development, Data Science, Development Project Management, Early Development, Immuno-Oncology Development, Medical Affairs, M&D Strategy & Operations, Oncology Development, Pharmacovigilance, Regulatory Affairs
Close

Hideki Shima Chief Manufacturing Officer (CMfgO)

Organization in charge

CMfgO Office, BioPharma Manufacturing, CMC Development, CMC Product Management, CMC Research, Pharma Manufacturing, Supply Chain Management, Technology & Manufacturing Capability and Compliance
Close

Claus Zieler Chief Commercial Officer (CCO)

Organization in charge

CCO Office, China Commercial, Established Markets Commercial, International Markets Commercial, Japan Commercial, United States Commercial, Commercial Capabilities, Market Access & Pricing, New Product Planning, Strategic Brand Marketing Medical Specialties, Strategic Brand Marketing Oncology, Strategic Brand Marketing Ophthalmics and Rare Disease
Close

Adam Pearson Chief Strategy Officer (CStO)

Organization in charge

Corporate CxO Office, Business Development, Corporate Strategy, iota Biosciences, Patient Centricity, Primary Focus Lead Blindness & Beyond, Primary Focus Lead Genetic Regulation, Primary Focus Lead Immune Homeostasis, Primary Focus Lead Immuno-Oncology, Primary Focus Lead Mitochondria, Primary Focus Lead Targeted Protein Degradation, Rx+ Business Accelerator, Sustainability
Close

Nick Eshkenazi Chief Digital & Transformation Officer (CDTO)

Organization in charge

DigitalX, Transformation Office
Close

Atsushi Kitamura Chief Financial Officer (CFO)

Organization in charge

CFO Office, Corporate Accounting & Global Business Services, Corporate Finance & Control, Procurement, Treasury & Tax
Close

Catherine Levitt General Counsel (GC)

Organization in charge

GC Office, Legal and IP
Close

Executive Committee (as of April 2024)

Astellas has the Executive Committee, chaired by the Representative Director, President and CEO, as a body for discussion on important matters in global management of the Astellas Group. Members consist of Top Management.

Members